1. Home
  2. PGEN vs TNC Comparison

PGEN vs TNC Comparison

Compare PGEN & TNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$5.64

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo Tennant Company

TNC

Tennant Company

HOLD

Current Price

$87.48

Market Cap

1.6B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
PGEN
TNC
Founded
1998
1870
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.6B
IPO Year
2013
1994

Fundamental Metrics

Financial Performance
Metric
PGEN
TNC
Price
$5.64
$87.48
Analyst Decision
Buy
Buy
Analyst Count
5
2
Target Price
$8.33
$79.00
AVG Volume (30 Days)
5.5M
151.6K
Earning Date
05-13-2026
05-04-2026
Dividend Yield
N/A
1.53%
EPS Growth
N/A
N/A
EPS
N/A
0.01
Revenue
$230,981,000.00
$1,137,600,000.00
Revenue This Year
$1,115.92
$5.77
Revenue Next Year
$81.04
$4.95
P/E Ratio
N/A
$8,748.00
Revenue Growth
N/A
N/A
52 Week Low
$1.47
$60.18
52 Week High
$6.04
$91.93

Technical Indicators

Market Signals
Indicator
PGEN
TNC
Relative Strength Index (RSI) 64.35 51.99
Support Level $3.32 $79.15
Resistance Level N/A $88.53
Average True Range (ATR) 0.34 2.31
MACD 0.06 -0.38
Stochastic Oscillator 75.46 33.43

Price Performance

Historical Comparison
PGEN
TNC

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

About TNC Tennant Company

Tennant Co is engaged in designing, manufacturing and marketing solutions that empower customers to achieve quality cleaning performance, reduce environmental impact and help create a cleaner, safer, healthier world. The Company is committed to creating and commercializing breakthrough, sustainable cleaning innovations to enhance its broad suite of products, including floor maintenance and cleaning equipment, detergent-free and other sustainable cleaning technologies, aftermarket parts and consumables, equipment maintenance and repair service, and asset management solutions. Its products are used in many types of environments, including retail establishments, distribution centers, factories and warehouses, public venues such as arenas and stadiums, office buildings, schools, and more.

Share on Social Networks: